Tag: Teleflex
US FDA grants premarket approval of MANTA vascular closure device
The US Food and Drug Administration (FDA) has given premarket approval (PMA) for the MANTA vascular closure device from Teleflex. This device is the...
12-month data show UroLift system a good treatment option for men...
Twelve-month data from the multicentre prospective MedLift study of the Urolift system (NeoTract, a Teleflex subsidiary) for benign prostatic hyperplasia (BPH) involving a median...
New products showcased at SIR 2018
There were several devices in the New Product Showcase at the Society of Interventional Radiology's Annual Scientific Meeting in Los Angeles, USA. Among these...
Teleflex gets new CEO
Teleflex has announced that it has completed its previously announced senior leadership transition with Liam Kelly succeeding Benson Smith as president and chief executive...
Teleflex completes acquisition of UroLift creator, NeoTract
Teleflex has announced the completion of its previously announced acquisition of NeoTract.
Founded in 2004, NeoTract is a privately-held medical device company that has developed...
Teleflex completes acquisition of Vascular Solutions
Teleflex Incorporated has completed its previously announced acquisition of Vascular Solutions.
On December 2, 2016, the two companies announced a definitive agreement for Teleflex...
Teleflex gets US FDA nod for Arrow VPS Rhythm with optional...
Teleflex has announced that its Arrow VPS Rhythm device with optional TipTracker technology has been issued 510(k) clearance so that the device can be...
Teleflex receives US FDA clearance for Arrow and TightTrack tunneler
Teleflex has announced that it has received US FDA 510(k) clearance to market its Arrow JACC with Chlorag+ard technology and TightTrack tunneler.
Arrow JACC...
